Cresemba

Active Ingredient(s): Isavuconazonium Sulfate
FDA Approved: * March 6, 2015
Pharm Company: * ASTELLAS
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cresemba Overview

Isavuconazonium sulfate (BAL8557; trade name Cresemba) is a prodrug for isavuconazole which is a triazole antifungal agent. Isavuconazonium is used to treat invasive aspergillosis and invasive mucormycosis.[1][2][3] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 6 Chemistry 7 History 8 References Medical uses Isavuconazonium is used to treat invasive aspergillosis and invasive mucormycosis ...

Read more Cresemba Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Isavuconazole

Recent Cresemba Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Isavuconazonium Sulfate
  • Capsule: 186mg
  • Injection: 372mg
  • Powder: 372mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cresemba: (3 results)

Sorted by National Drug Code
  • 0469-0320 Cresemba 186 mg Oral Capsule by Astellas Pharma Us, Inc.
  • 0469-0420 Cresemba 74.4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us, Inc.
  • 0469-0520 Cresemba 186 mg Oral Capsule by Astellas Pharma Us, Inc.

Other drugs which contain Isavuconazonium Sulfate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA